Charting the cellular biogeography in colitis reveals fibroblast trajectories and coordinated spatial remodeling

Paolo Cadinu, Kisha N. Sivanathan, Aditya Misra, +18

Cell

InflammationMucosal ImmunologyMedicineGastroenterologyPathology +6

Propranolol induces a favourable shift of anti-tumor immunity in a murine spontaneous model of melanoma

Ludovic J. Wrobel, Lloyd Bod, Renée Lengagne, +3

Oncotarget

Checkpoint Receptor TIGIT Expressed on Tim-1+ B Cells Regulates Tissue Inflammation

Sheng Xiao, Lloyd Bod, Nathalie Pochet, +13

Cell Reports

IL-4–Induced Gene 1: A Negative Immune Checkpoint Controlling B Cell Differentiation and Activation

Lloyd Bod, Laëtitia Douguet, Cédric Auffray, +7

The Journal of Immunology

Emerging Role of IL-4–Induced Gene 1 as a Prognostic Biomarker Affecting the Local T-Cell Response in Human Cutaneous Melanoma

Jan Philipp Ramspott, Fériel Bekkat, Lloyd Bod, +10

Journal of Investigative Dermatology

Cancer ImmunosurveillanceHuman Cutaneous MelanomaLocal T-cell ResponseImmune Cell DevelopmentMelanoma +10

IL4-induced gene 1 promotes tumor growth by shaping the immune microenvironment in melanoma

Lloyd Bod, Renée Lengagne, Ludovic J. Wrobel, +6

OncoImmunology

Nitric oxide synthase 2 is involved in the pro-tumorigenic potential of γδ17 T cells in melanoma

Laëtitia Douguet, Lloyd Bod, Renée Lengagne, +4

OncoImmunology

Lymphocyte DevelopmentImmunologyImmune RegulationImmunoeditingImmunologic Mechanism +18

Nitric Oxide Synthase 2 Improves Proliferation and Glycolysis of Peripheral γδ T Cells

Laëtitia Douguet, Julien Cherfils‐Vicini, Lloyd Bod, +3

PLoS ONE

γδ T CellsGlycolysis MetabolismBiochemistryReactive Nitrogen SpecieImmunology +13

Charting the cellular biogeography in colitis reveals fibroblast trajectories and coordinated spatial remodeling

Paolo Cadinu, Kisha N. Sivanathan, Aditya Misra, +17

Inflammation drives nitric oxide synthase 2 expression by γδ T cells and affects the balance between melanoma and vitiligo associated melanoma

Laëtitia Douguet, Lloyd Bod, Laura Labarthe, +4

OncoImmunology